Loading clinical trials...

Phase 2a Study of HPG1860 in Subjects With NASH | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT05338034

Phase 2a Study of HPG1860 in Subjects With NASH

This is a Phase 2a, randomized, double-blind, placebo-controlled, parallel group, multiple arm, multicenter study of 3 different doses of HPG1860 versus placebo in subjects with biopsy-confirmed or ph...

Lead sponsor: Hepagene (Shanghai) Co., Ltd.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis

NCT03587831 · NASH - Nonalcoholic Steatohepatitis

RECRUITINGPhase 2

Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)

NCT04697810 · NASH - Nonalcoholic Steatohepatitis

Active Not Recruiting

Novel MRE Technique to Assess a Risk Factor for Liver Cancer

NCT05165446 · NASH - Nonalcoholic Steatohepatitis

Active Not RecruitingNA

Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis

NCT04383951 · NASH - Nonalcoholic Steatohepatitis, Cirrhosis, Liver

Active Not RecruitingPhase 2

Tocotrienol Against the Progression of End Stage Liver Disease

NCT02581085 · End Stage Liver Disease, NASH - Nonalcoholic Steatohepatitis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 28, 2026Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment89

Start dateNov 2021

Last updatedMay 28, 2026

Condition

NASH - Nonalcoholic Steatohepatitis

Locations shown

South Texas Research Institute (STRI)

Texas City, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 28, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions